Clinical Trial Update: Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK2330672 in adults with Type 2 diabetes mellitus on metformin; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK2330672

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2017-08-16